Connect Sign In
Inhibin B
Ordering Recommendation
Use to differentiate ovarian tumor with normal CA 125 as stromal or mucinous epithelial tumor. May be used for monitoring recurrence of stromal ovarian tumors.
New York DOH Approval Status
Specimen Required
For premenopausal females, collection is preferred during the follicular phase of the menstrual cycle.
Serum separator tube or plain red.
Transport 0.5 mL serum. (Min: 0.2 mL)
Frozen.
Room temperature specimens. Grossly hemolyzed specimens. Plasma
After separation from cells: Ambient: Unacceptable; Refrigerated: 72 hours; Frozen: 1 month
Methodology
Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)
Performed
Wed, Fri
Reported
1-8 days
Reference Interval
| Male |
Female |
|---|---|
| <15 days: 68-373 pg/mL 15 days-6 months: 42-516 pg/mL 7 months-7 years: 24-300 pg/mL 8-30 years: 47-383 pg/mL 31-72 years: 10-357 pg/mL |
1 day-12 years: <=182 pg/mL 13-41 years (regular cycle, follicular phase): 8-223 pg/mL 42-51 years (regular cycle, follicular phase): <=107 pg/mL 51-76 years (postmenopausal): <=11 pg/mL |
Interpretive Data
This test is performed using the ANSH ultra-sensitive Inhibin B ELISA kit. Values obtained with different methodologies or kits cannot be used interchangeably.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
CPT Codes
83520
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0070413 | Inhibin B | 34319-4 |
